Eversion endarterectomy under full prasugrel treatment

The third-generation thienopyridine prasugrel has much stronger antiplatelet effect compared to other current antiplatelet inhibitors and exhibits practically zero resistance in healthy people. Prasugrel is used as a pre- and post-treatment in percutaneous coronary or neurovascular interventions wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotsis, Thomas, Christoforou, Panagitsa, Asaloumidis, Nikolaos, Argyra, Erifyli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692133/
https://www.ncbi.nlm.nih.gov/pubmed/29163956
http://dx.doi.org/10.1177/2050313X17741826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692133/
https://www.ncbi.nlm.nih.gov/pubmed/29163956
http://dx.doi.org/10.1177/2050313X17741826

Ejemplares similares